-The Hindu In the area of intellectual property, public health and access to medicines, the Narendra Modi government should consider its independence to be of the utmost importance. Strong government leadership as well as flexible intellectual property systems are needed in order to effectively combat drug-resistant tuberculosis (DR-TB) and HIV and also antimicrobial resistance and non-communicable diseases. This is true not only for India but also countries which rely on affordable generic...

-The Indian Express Bedaquiline, which is a drug for Multi-Drug Resistant TB, is being introduced at six identified tertiary care centres across India. The Union Health Ministry has introduced Bedaquiline into the national tuberculosis (TB) programme. This was among several initiatives Health Minister J P Nadda launched on Monday. Bedaquiline, which is a drug for Multi-Drug Resistant TB, is being introduced at six identified tertiary care centres across India. The sites have...

-The Hindu The Modi government must stop engaging U.S. bureaucrats as patent consultants and instead showcase the Indian patent statute as an exemplar for a balanced regime Earlier this month, the media reported that India “privately” assured the United States that it will not issue any more compulsory licenses. This report was reminiscent of a theory propounded by psychologist Lenore E. Walker in 1979 on abusive patterns in relationships. Four stages of abuse Walker...

-The Hindu The Lawyers Collective has issued a clarification on March 10 on issues relating to allegations of violating the Foreign Contribution (Regulation) Act, 2010. Lawyers Collective (LC) has accused the government of making a “deliberate and sustained effort to target and vilify” the 35-year-old public trust and its chief functionaries, including former Additional Solicitor General Indira Jaising, by accusing them of violations under the Foreign Contribution (Regulation) (FCRA) Act, 2010. In a...

-The Hindu Medicines remain overpriced and unaffordable in India. In a country mired in poverty, medical debt remains the second biggest factor for keeping millions in poverty. The international pharmaceutical industry has found its cash cow in India’s beleaguered consumers. With a minimum wage of Rs.250/day for a government worker, a basic wage worker afflicted with a chronic disease like multi-drug-resistant tuberculosis faces penury. His treatment, with drug combinations, which works out...